JPRN-UMIN000017266招募中2 期
A phase II randomized controlled trial on effect of digestive enzymes for the development of nonalcoholic fatty liver disease (NAFLD) after pancreaticoduodenectomy. - A phase II randomized controlled trial on effect of digestive enzymes for the development of nonalcoholic fatty liver disease (NAFLD) after pancreaticoduodenectomy.
ational Defense Medical College0 个研究点目标入组 100 人开始时间: 2015年4月24日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Preoperative fatty liver Positive HBs antigen or HCV antibody alcohol abuse total pancreatectomy R2 operation Gastrointestinal disease with malabsorption Other reason that attending doctors consider
研究者
相似试验
进行中（未招募）
1 期
Study to assess the effect of intensive vs standard adjuvant chemotherapy in localised colon cancer with circulating tumor DNA.ocalised Colon Cancer (stage II-III)MedDRA version: 21.0Level: PTClassification code 10009954Term: Colon cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10009955Term: Colon cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-000507-20-ESInstituto de Investigación Sanitaria INCLIVA164
尚未招募
2 期
A randomised phase 2 study of carboplatin with oral vinorelbine followed by maintenance therapy with oral vinorelbine or erlotinib in elderly patients with metastatic non-small cell lung cancer.on Small Cell Lung CancerNon Small Cell Lung CancerCancer - Lung - Non small cellACTRN12612000473864Southern Health100
招募中
2 期
A randomized phase II study to evaluate efficacy of negative pressure wound therapy on prophylaxis of the incisional hernia after reversal of temporaly diverting stomatemporally diverting stoma to be planned to have closedJPRN-UMIN000030936Aichi Medical University70
进行中（未招募）
不适用
A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab pre-treated patients with HER2-positive metastatic breast cancer - E-VITAMETASTATIC BREAST CANCER in HER2 positiv PatientsMedDRA version: 14.1Level: PTClassification code 10055113Term: Breast cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-023237-37-DEGBG Forschungs GmbH (German Breast Group)80
招募中
2 期
A randomised phase II study to evaluate the effectiveness of botulinum toxin to delay, and possibly prevent, progressive foot deformities in children with Charcot-Marie-Tooth (CMT) disease.Charcot-Marie-Tooth diseaseHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersNeurological - Other neurological disordersACTRN12605000115639The Children's Hospital at Westmead10